• Wion
  • /India News
  • /Indian pharma Cadila seeks approval to repurpose Hepatitis C drug for COVID-19

Indian pharma Cadila seeks approval to repurpose Hepatitis C drug for COVID-19

Indian pharma Cadila Healthcare has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial.